• OPEN AN ACCOUNT
A+| A| A-|
Indian Indices
Sensex
74,563.92 -1,470.50
( -1.93%)
Global Indices
Nasdaq
46,583.62 -115.24
(-0.25%)
Dow Jones
6,653.27 -40.35
(-0.60%)
Hang Seng
53,838.16 -614.80
(-1.13%)
Nikkei 225
10,249.42 -55.73
(-0.54%)
Forex
USD-INR
92.29 0.37
(0.40%)
EUR-INR
106.44 -0.15
(-0.14%)
GBP-INR
123.36 -0.03
(-0.03%)
JPY-INR
0.58 0.00
(0.05%)

EQUITY - MARKET SCREENER

Cipla Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
ISIN Demat
Book Value()
500087
INE059A01026
411.5552288
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
CIPLA
23.17
106150.46
EPS(TTM)
Face Value()
Div & Yield %
56.72
2
1.22
 

sanofi india ltd
IndiaMART shares rally on Nalanda Capital bulk deal buy
Jan 16,2026
According to exchange data, Nalanda India Equity Fund, managed by Nalanda Capital, acquired 11.18 lakh shares, representing a 1.86% stake, at Rs 2,110 per share.

In the same transaction, Small Cap World Fund, managed by Capital Group, sold 6.26 lakh shares, or a 1.04% stake, for Rs 132.17 crore at the same price. The fund held a 1.83% stake in the company at the end of the September quarter.

IndiaMART's promoters currently hold a 49.17% stake. The company's shareholding pattern for the December quarter is yet to be released.

IndiaMART is India's largest online B2B marketplace for business products and services.

On a consolidated basis, net profit of IndiaMART InterMESH declined 38.79% to Rs 82.70 crore while net sales rose 12.45% to Rs 391.00 crore in Q2 September 2025 over Q2 September 2024.